Notably, Rapamycin (sirolimus), an mTOR inhibitor, has demonstrated its efficacy in various instances involving patients with CLOVES syndrome, leading to improvements in adipose overgrowth, vascular irregularities, and overall quality of life [11,12]. Here, MTOR is linked to CLOVE syndrome.